Brian K. Kaspar Insider Trading $AVXS AveXis, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian K. Kaspar.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian K. Kaspar. Brian K. Kaspar is Chief Scientific Officer in AveXis, Inc. ($AVXS).
Brian K. Kaspar in AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Brian K. Kaspar: Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Brian K. Kaspar in AveXis, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | D | 77.24 | 32,501 | 2,510,377 | 0 | |
| May 15 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | D | 0.00 | 1,764,142 | 0 | 0 | 1.8 M to 0 (-100.00 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 123.16 | 846 | 104,193 | 1,755,602 | 1.8 M to 1.8 M (-0.05 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 122.29 | 1,182 | 144,547 | 1,756,558 | 1.8 M to 1.8 M (-0.07 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 121.64 | 929 | 113,004 | 1,757,630 | 1.8 M to 1.8 M (-0.05 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 120.18 | 3,179 | 382,052 | 1,758,559 | 1.8 M to 1.8 M (-0.18 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 119.29 | 4,021 | 479,665 | 1,761,738 | 1.8 M to 1.8 M (-0.23 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 118.17 | 2,007 | 237,167 | 1,765,759 | 1.8 M to 1.8 M (-0.11 %) |
| Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 117.00 | 2,836 | 331,812 | 1,767,766 | 1.8 M to 1.8 M (-0.16 %) |
| Mar 27 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
| Mar 27 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Grant | A | 0.00 | 3,800 | 0 | 1,770,602 | 1.8 M to 1.8 M (+0.22 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 122.83 | 100 | 12,283 | 1,781,802 | 1.8 M to 1.8 M (-0.01 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 121.95 | 208 | 25,366 | 1,781,902 | 1.8 M to 1.8 M (-0.01 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 121.17 | 918 | 111,234 | 1,782,110 | 1.8 M to 1.8 M (-0.05 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 120.14 | 993 | 119,299 | 1,783,028 | 1.8 M to 1.8 M (-0.06 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 118.67 | 908 | 107,752 | 1,784,021 | 1.8 M to 1.8 M (-0.05 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 117.79 | 7,218 | 850,208 | 1,784,929 | 1.8 M to 1.8 M (-0.40 %) |
| Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 117.05 | 4,655 | 544,868 | 1,792,147 | 1.8 M to 1.8 M (-0.26 %) |
| Jan 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 110.58 | 1,838 | 203,246 | 1,796,802 | 1.8 M to 1.8 M (-0.10 %) |
| Jan 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 109.87 | 9,746 | 1,070,793 | 1,798,640 | 1.8 M to 1.8 M (-0.54 %) |
| Jan 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 108.95 | 3,416 | 372,173 | 1,808,386 | 1.8 M to 1.8 M (-0.19 %) |
| Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 95.95 | 1,134 | 108,807 | 1,811,802 | 1.8 M to 1.8 M (-0.06 %) |
| Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 95.00 | 9,810 | 931,950 | 1,812,936 | 1.8 M to 1.8 M (-0.54 %) |
| Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 94.14 | 2,685 | 252,766 | 1,822,746 | 1.8 M to 1.8 M (-0.15 %) |
| Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 93.27 | 1,071 | 99,892 | 1,825,431 | 1.8 M to 1.8 M (-0.06 %) |
| Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 91.84 | 300 | 27,552 | 1,826,502 | 1.8 M to 1.8 M (-0.02 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 106.17 | 545 | 57,863 | 1,826,802 | 1.8 M to 1.8 M (-0.03 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 105.40 | 766 | 80,736 | 1,827,347 | 1.8 M to 1.8 M (-0.04 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 104.67 | 1,463 | 153,132 | 1,828,113 | 1.8 M to 1.8 M (-0.08 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 103.16 | 513 | 52,921 | 1,829,576 | 1.8 M to 1.8 M (-0.03 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 102.13 | 1,071 | 109,381 | 1,830,089 | 1.8 M to 1.8 M (-0.06 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.77 | 2,128 | 214,439 | 1,831,160 | 1.8 M to 1.8 M (-0.12 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.24 | 6,453 | 646,849 | 1,833,288 | 1.8 M to 1.8 M (-0.35 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 98.85 | 1,278 | 126,330 | 1,839,741 | 1.8 M to 1.8 M (-0.07 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 98.04 | 783 | 76,765 | 1,841,019 | 1.8 M to 1.8 M (-0.04 %) |
| Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 103.60 | 1,175 | 121,730 | 1,841,802 | 1.8 M to 1.8 M (-0.06 %) |
| Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 102.70 | 1,559 | 160,109 | 1,842,977 | 1.8 M to 1.8 M (-0.08 %) |
| Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 101.55 | 6,767 | 687,189 | 1,844,536 | 1.9 M to 1.8 M (-0.37 %) |
| Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.53 | 5,499 | 552,814 | 1,851,303 | 1.9 M to 1.9 M (-0.30 %) |
| May 12 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | A | 77.24 | 32,501 | 2,510,377 | 32,501 |
Page: 1